Darren Feldman, MD

Medical Oncologist - GU Cancers
MSKCC

Memorial Sloan Kettering Cancer Center Chair of Quality Assurance in the Department of Medicine, and Section Head of Germ Cell Cancer.

Poster(s):

• 70: Phase 2 Study of Nivolumab plus 177Lutetium-labeled Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Clear Cell Renal Cell Carcinoma